Follow
Khadega Abuelgasim
Khadega Abuelgasim
Helen F Graham Cancer Center and Research Institute
Verified email at christianacare.org
Title
Cited by
Cited by
Year
The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia
KA Abuelgasim, Y Alsharhan, T Alenzi, A Alhazzani, YZ Ali, AR Jazieh
BMC Complementary and Alternative Medicine 18, 1-8, 2018
1022018
Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism
DA McClain, KA Abuelgasim, M Nouraie, J Salomon-Andonie, X Niu, ...
Journal of molecular medicine 91, 59-67, 2013
562013
Depression and anxiety in patients with hematological malignancies, prevalence, and associated factors
KA Abuelgasim, GY Ahmed, JA Alqahtani, AM Alayed, AS Alaskar, ...
Saudi medical journal 37 (8), 877, 2016
382016
Highlights of the management of adult histiocytic disorders: Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis
HA Salama, AR Jazieh, AY Alhejazi, A Absi, S Alshieban, M Alzahrani, ...
Clinical Lymphoma Myeloma and Leukemia 21 (1), e66-e75, 2021
342021
The trends of complementary alternative medicine use among cancer patients
AR Jazieh, KA Abuelgasim, HI Ardah, M Alkaiyat, OB Da’ar
BMC Complementary Medicine and Therapies 21 (1), 167, 2021
202021
Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma
KA Abuelgasim, M Alzahrani, Y Alsharhan, M Khairi, M Hommady, ...
Bone Marrow Transplantation 54 (7), 1168-1172, 2019
192019
Reactivation of tuberculosis following ruxolitinib therapy for primary myelofibrosis: case series and literature review
F Khalid, M Damlaj, M AlZahrani, KA Abuelgasim, GE Gmati
Hematology/Oncology and Stem Cell Therapy 14 (3), 252-256, 2021
172021
Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review
KA Abuelgasim, B Albuhayri, R Munshi, A Al Mugairi, B Alahmari, G Gmati, ...
Leukemia Research Reports 14, 100206, 2020
152020
Pre-autologous transplantation PET/CT using Deauville criteria is an independent predictor of progression in relapsed refractory classical Hodgkin lymphoma
M Damlaj, S Ghazi, G Syed, T Pasha, G Gmati, H Salama, O Ali, ...
Bone marrow transplantation 52 (9), 1342-1344, 2017
142017
Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature
KA Abuelgasim, H Rehan, M Alsubaie, N Al Atwi, M Al Balwi, S Alshieban, ...
Journal of Medical Case Reports 12, 1-8, 2018
122018
An atypical initial presentation of chronic myeloid leukemia with central nervous system and lymph node blast crises
KA Abuelgasim, S Alshieban, NA Almubayi, A Alhejazi, AR Jazieh
Case Reports in Oncology 9 (2), 415-421, 2016
102016
Electronic early notification of sepsis in hospitalized ward patients: a study protocol for a stepped-wedge cluster randomized controlled trial
YM Arabi, A Alsaawi, M Al Zahrani, AM Al Khathaami, RH AlHazme, ...
Trials 22, 1-12, 2021
92021
Incidence and predictors of recurrence and mortality following first venous thromboembolism among the Saudi population: single-center cohort study
FAS AlEidan, RK AlManea, AT AlMoneef, NA Shalash, NA AlRajhi, ...
International Journal of General Medicine 15, 7559, 2022
72022
Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience
KA Abuelgasim, R Al Shammari, S Alshieban, B Alahmari, M Alzahrani, ...
Leukemia Research Reports 15, 100240, 2021
72021
Outcome of age-adapted approach to HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: Saudi experience
M Alzahrani, M Damlaj, M Essa, B Alahmari, A Alaskar, A Hejazi, ...
Blood 132, 3468, 2018
62018
Venetoclax in combination with carfilzomib and dexamethasone in relapsed/refractory multiple myeloma harboring t (11, 14)(q13; q32): two case reports and a review of the literature
KA Abuelgasim, N Alherz, A Alhejazi, M Damlaj
Journal of Medical Case Reports 14, 1-6, 2020
52020
The trends of cancer patients’ perceptions on the causes and risk factors of cancer over time
AR Jazieh, M Alkaiyat, KA Abuelgasim, H Ardah
Saudi Medical Journal 43 (5), 479, 2022
42022
Isolated Bone Marrow Non–Langerhans Cell Histiocytosis Preceding RUNX1-Mutated Acute Myeloid Leukemia: Case Report and Literature Review
A Al Mugairi, S Al Turki, H Salama, K Al Ahmadi, KA Abuelgasim, ...
American Journal of Clinical Pathology 151 (6), 638-646, 2019
42019
Method of treating leukemia based on gene expression of clock genes
M Boudjelal, A Al Askar, A Alhallaj, A Nehdi, H Rehan, S Rahman, ...
US Patent 10,253,371, 2019
42019
A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment
A Nehdi, N Samman, A Mashhour, A Alhallaj, T Trivilegio, S Gul, ...
Frontiers in Oncology 11, 579488, 2021
32021
The system can't perform the operation now. Try again later.
Articles 1–20